United States· US:50090-0757_80023785-4b99-48c1-b757-c391056fe6fc

Lovastatin

A lovastatin product containing lovastatin, registered in United States by A-S Medication Solutions. The same ATC class is registered in 10 of our 19 countries.

ATC C10AA02Orange BookUS label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedLovastatinATCC10AA02REGISTER NO.US:50090-0757_8002378…PACKS LISTED2CHECKEDSeptember 12, 2026

Where it is registered

Lovastatin is registered in 10 of 19 countries.

Countries holding a registration under ATC C10AA02 (lovastatin), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 7 of them publish a price we can compare per daily dose

Lovastatin · ATC C10AA02

10 / 19 countries

  • Canada
  • Czechiaprice
  • Finlandprice
  • Germany
  • Italyprice
  • Norwayprice
  • Polandprice
  • Spainprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of lovastatin costs, country by country.

Normalised to the WHO defined daily dose (45 mg), the median price runs from $0.20 in Spain to $0.55 in Italy — a ×2.7 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Lovastatin · price per daily dose (45 mg)

USD · FX 28 Sept 2026

  • IT Italy$0.55
  • ES Spain$0.20
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
Lovastatin
Manufacturer
A-S Medication Solutions
Country
United States (US)
ATC code
C10AA02
ATC class
Lovastatin
Defined daily dose
45 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 12, 2026

Packs & prices · 2

  • ndc11
    5009007570
    30 TABLET in 1 BOTTLE (50090-0757-0)
  • ndc11
    5009007571
    90 TABLET in 1 BOTTLE (50090-0757-1)

Regulatory notes

UNII (FDA substance ID)
9LHU78OQFD
LOVASTATIN
RxCUI 6472
Orange Book
A075991
ABABAB
DailyMed SPL labels
1 version tracked

Interactions

338 interactions on record for lovastatin.

Graded by severity as the source publishes them — 17 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Lovastatin · interactions on record

338 records

  • 17 severe
  • 176 moderate
  • 4 minor
  • 140 info

Most severe, free to view

  • KetoconazoleH02CA03severe
  • ErythromycinJ01FA01severe
  • ClarithromycinJ01FA09severe
  • KetoconazoleJ02AB02severe

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Lovastatin in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lovastatin products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

  • Cyprus · Lovarem, Lovasynt
  • Czechia · Medostatin
  • Germany · Lovabeta
  • Denmark · Lovacodan
  • Spain · Colesvir, Lovastatina Cinfa
  • Greece · Lovatex, Velkalov
  • Italy · Lovastatina Doc, Lovastatina Eg
  • Malta · Medostatin
  • Poland · Liprox, Lovasterol
  • Portugal · Lipdaune, Lipus
  • Romania · Lovastatină Arena

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c5954f1a-6d54-4d3e-be63-da2b73400a2a
GET /v1/drugs/c5954f1a-6d54-4d3e-be63-da2b73400a2a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unii": {
    "unii": "9LHU78OQFD",
    "rxcui": "6472",
    "inchikey": "PCZOHLXUXFIOCF-BXMDZJJMSA-N",
    "display_name": "LOVASTATIN",
    "substance_type": "chemical",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "ORAL",
  "livertox": {
    "summary": null,
    "livertox_id": null,
    "hepatotoxicity_score": 2
  },
  "spl_meta": {
    "f5f265a6-2aa5-4205-9159-40133ae93ac0": {
      "match": "brand_token",
      "title": "LOVASTATIN TABLET [BRYANT RANCH PREPACK]",
      "spl_version": "8",
      "published_date": "2026-06-01"
    }
  },
  "productid": "50090-0757_80023785-4b99-48c1-b757-c391056fe6fc",
  "productndc": "50090-0757",
  "dosage_form": "TABLET",
  "orange_book": {
    "appl_no": "075991",
    "products": [
      {
        "rs": false,
        "rld": false,
        "te_code": "AB",
        "strength": "10MG",
        "product_no": "001",
        "approval_date": "Jun 5, 2002"
      },
      {
        "rs": false,
        "rld": false,
        "te_code": "AB",
        "strength": "20MG",
        "product_no": "002",
        "approval_date": "Jun 5, 2002"
      },
      {
        "rs": true,
        "rld": false,
        "te_code": "AB",
        "strength": "40MG",
        "product_no": "003",
        "approval_date": "Jun 5, 2002"
      }
    ],
    "appl_type": "A"
  },
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "LOVASTATIN",
  "proprietary_name": "Lovastatin",
  "active_ingred_unit": "mg/1",
  "application_number": "ANDA075991",
  "marketing_category": "ANDA",
  "nonproprietary_name": "Lovastatin",
  "start_marketing_date": "20021125",
  "active_numerator_strength": "10"
}

See everything about lovastatin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.